Request a document copy: Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study

all files (of this document) in restricted access
the file(s) you requested
Cancel